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Recent evidence has conﬁrmed the presence of large numbers of bacteria coexisting
in the CF airways. The clinical signiﬁcance of this ﬁnding is yet to be determined. In
this pilot study, we sought to investigate the complexity of the airway microbiome
of children with CF and compare this to the microbiome present in the non-CF
airways.
BAL ﬂuid and oropharyngeal swabs (OS) from children with CF and BAL from
non-CF controls were collected. DNA was isolated from 12 CF BAL and paired
OS and 10 non-CF control BALs. The 16S rRNA region from all bacterial DNA
was ampliﬁed, fragmented, biotinylated and hybridised to an advanced microarray
containing taxa speciﬁc probes for 50,000 bacterial species. Quantitative PCR was
performed to support PhyloChip results. Demographic data on patient’s age, sex,
CFTR mutation and details on antibiotic exposure was also recorded.
We found a sizeable microbial community present in the non-CF airways. The
microbial community in the lower airways of children without CF was signiﬁcantly
more diverse than that of the CF lower airways. A subset of the bacterial community
(30% of taxa) differs signiﬁcantly between the CF and non-CF airway. In particular
the Peptostreptococcaceae, Enterobactericeae and Moraxellaceae families are the
most predictive of patient group. An increase in age was associated with an increase
in microbiome diversity in our CF group. We are now planning a 3 year prospective
study to conﬁrm these ﬁndings and determine their clinical relevance.
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Background: Chronic bacterial pulmonary infection in cystic ﬁbrosis (CF) causes
progressive irreversible lung damage. Culture-independent techniques have high-
lighted the complex polymicrobial microbiota associated with adult CF airways.
However, far less is known about the microbiology of the lower respiratory tract
(LRT) in young children with CF.
Aim: To use 16S rRNA gene pyrosequencing of bronchoalveolar lavage ﬂuid
(BALF) to compare the microbiota of the LRT of young children with and
without CF.
Methods: BALF was obtained from young children (<18 months age) with CF
(n = 8) and without CF (n = 6). DNA was extracted from the BALF samples and 16S
rRNA genes were ampliﬁed by PCR using barcoded primers for downstream DNA
sequencing using 454 Titanium pyrosequencing. ~5,500 high quality sequences
were used for further analysis.
Results: 16S rRNA gene sequence analysis revealed signiﬁcant differences in
LRT bacterial community composition between the CF and non-CF children. CF
children were characterized by an increased proportional abundance of potentially
pathogenic microorganisms such as Pseudomonas aeruginosa (p< 0.001) and
Stenotrophomonas maltophilia (p< 0.001) compared to non-CF children. In con-
trast, the LRT of non-CF children appeared to be colonised by mainly “commensal”
microbes. There was no signature proﬁle associated with CF disease, however, and
inter-individual variation between children was high.
Conclusion: Our results provide novel information on the microbiota of the lung in
young children. Even in early life the CF lung has a distinct microbial constitution
and already includes a number of potentially pathogenic species.
